Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 17 | 2022 | 454 | 2.650 |
Why?
|
Lymphatic Abnormalities | 7 | 2019 | 133 | 2.440 |
Why?
|
Hemangioendothelioma | 6 | 2018 | 121 | 1.620 |
Why?
|
Sarcoma, Kaposi | 5 | 2016 | 370 | 1.330 |
Why?
|
Thrombosis | 13 | 2018 | 2968 | 1.320 |
Why?
|
Sirolimus | 7 | 2021 | 1564 | 0.980 |
Why?
|
Thrombophilia | 5 | 2013 | 305 | 0.880 |
Why?
|
Esophageal Atresia | 2 | 2016 | 201 | 0.830 |
Why?
|
Angiomatosis | 2 | 2017 | 49 | 0.720 |
Why?
|
Osteolysis, Essential | 2 | 2018 | 30 | 0.660 |
Why?
|
Thromboembolism | 2 | 2014 | 986 | 0.600 |
Why?
|
Expert Testimony | 1 | 2019 | 356 | 0.580 |
Why?
|
Neck | 2 | 2021 | 697 | 0.580 |
Why?
|
Colitis | 2 | 2014 | 1170 | 0.530 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2015 | 26 | 0.520 |
Why?
|
Perinatal Care | 1 | 2017 | 227 | 0.510 |
Why?
|
Venous Thromboembolism | 3 | 2020 | 1671 | 0.500 |
Why?
|
Skin Diseases | 3 | 2021 | 1065 | 0.490 |
Why?
|
Heparin | 3 | 2018 | 1637 | 0.480 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 101 | 0.480 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2014 | 2425 | 0.470 |
Why?
|
Pulmonary Embolism | 3 | 2018 | 2376 | 0.450 |
Why?
|
Anticoagulants | 5 | 2018 | 4599 | 0.450 |
Why?
|
Vincristine | 1 | 2015 | 1039 | 0.440 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 233 | 0.440 |
Why?
|
Infant | 28 | 2023 | 35136 | 0.440 |
Why?
|
Immunosuppressive Agents | 4 | 2021 | 4149 | 0.430 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 210 | 0.420 |
Why?
|
Infant, Newborn, Diseases | 1 | 2017 | 582 | 0.410 |
Why?
|
Face | 1 | 2017 | 994 | 0.390 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 624 | 0.390 |
Why?
|
Steroids | 1 | 2015 | 930 | 0.360 |
Why?
|
Thrombocytopenia | 2 | 2014 | 1179 | 0.350 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2011 | 188 | 0.350 |
Why?
|
Blood Coagulation | 5 | 2018 | 1127 | 0.350 |
Why?
|
Catheterization, Central Venous | 1 | 2014 | 514 | 0.340 |
Why?
|
Child, Preschool | 24 | 2021 | 41006 | 0.320 |
Why?
|
Child | 30 | 2023 | 77709 | 0.310 |
Why?
|
Stroke | 5 | 2023 | 9981 | 0.310 |
Why?
|
Cranial Sinuses | 2 | 2017 | 66 | 0.300 |
Why?
|
Fibrinolytic Agents | 2 | 2014 | 2158 | 0.290 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2018 | 95 | 0.290 |
Why?
|
Hemorrhage | 3 | 2018 | 3461 | 0.290 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 2 | 2018 | 68 | 0.280 |
Why?
|
Nevus | 2 | 2018 | 204 | 0.270 |
Why?
|
Lipoma | 2 | 2018 | 334 | 0.260 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 950 | 0.250 |
Why?
|
Lipoproteins | 1 | 2009 | 878 | 0.250 |
Why?
|
Infant, Newborn | 15 | 2021 | 25625 | 0.240 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2017 | 356 | 0.240 |
Why?
|
Adolescent | 24 | 2021 | 85781 | 0.230 |
Why?
|
Patient Care Team | 1 | 2015 | 2531 | 0.230 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.230 |
Why?
|
Cardiac Surgical Procedures | 5 | 2018 | 3537 | 0.210 |
Why?
|
Retrospective Studies | 21 | 2023 | 77449 | 0.210 |
Why?
|
Male | 44 | 2021 | 350118 | 0.210 |
Why?
|
Lymph Nodes | 1 | 2013 | 3474 | 0.210 |
Why?
|
Gene Deletion | 1 | 2009 | 2751 | 0.200 |
Why?
|
Humans | 66 | 2023 | 744343 | 0.200 |
Why?
|
Veins | 2 | 2018 | 770 | 0.200 |
Why?
|
Hematology | 2 | 2017 | 221 | 0.190 |
Why?
|
Quality Improvement | 1 | 2016 | 3749 | 0.190 |
Why?
|
Female | 42 | 2023 | 380194 | 0.190 |
Why?
|
Partial Thromboplastin Time | 2 | 2018 | 206 | 0.190 |
Why?
|
Transferrin | 2 | 2005 | 295 | 0.190 |
Why?
|
Factor Xa | 2 | 2018 | 162 | 0.180 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5172 | 0.180 |
Why?
|
Risk Factors | 15 | 2020 | 72290 | 0.180 |
Why?
|
Venous Thrombosis | 1 | 2009 | 1239 | 0.180 |
Why?
|
Heart Defects, Congenital | 4 | 2018 | 4584 | 0.180 |
Why?
|
Thalidomide | 2 | 2016 | 890 | 0.180 |
Why?
|
Sclerotherapy | 3 | 2019 | 175 | 0.170 |
Why?
|
Antibodies, Anticardiolipin | 3 | 2013 | 62 | 0.170 |
Why?
|
Ultrasonography, Prenatal | 2 | 2017 | 1695 | 0.170 |
Why?
|
Boston | 7 | 2022 | 9313 | 0.170 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11031 | 0.170 |
Why?
|
Young Adult | 16 | 2021 | 56430 | 0.170 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2019 | 54 | 0.160 |
Why?
|
Angiofibroma | 1 | 2019 | 68 | 0.160 |
Why?
|
Protein-Losing Enteropathies | 1 | 2018 | 45 | 0.160 |
Why?
|
Postoperative Complications | 4 | 2017 | 15295 | 0.160 |
Why?
|
Thoracic Duct | 1 | 2018 | 63 | 0.160 |
Why?
|
Chylothorax | 1 | 2018 | 84 | 0.150 |
Why?
|
Mucous Membrane | 1 | 2021 | 673 | 0.150 |
Why?
|
Cation Transport Proteins | 4 | 2001 | 327 | 0.150 |
Why?
|
Lower Extremity | 3 | 2020 | 1158 | 0.150 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3229 | 0.150 |
Why?
|
Varicose Veins | 1 | 2018 | 154 | 0.140 |
Why?
|
Angiopoietins | 1 | 2016 | 80 | 0.140 |
Why?
|
Upper Extremity | 2 | 2019 | 648 | 0.140 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 286 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1363 | 0.140 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 145 | 0.130 |
Why?
|
Platelet Function Tests | 1 | 2017 | 270 | 0.130 |
Why?
|
Endothelial Cells | 2 | 2022 | 3479 | 0.130 |
Why?
|
Muscular Diseases | 1 | 2020 | 556 | 0.130 |
Why?
|
Placenta Diseases | 1 | 2018 | 199 | 0.130 |
Why?
|
Cerebral Palsy | 1 | 2020 | 459 | 0.130 |
Why?
|
Head | 1 | 2021 | 880 | 0.130 |
Why?
|
Lymphatic System | 1 | 2016 | 253 | 0.130 |
Why?
|
Wnt Proteins | 1 | 2019 | 721 | 0.130 |
Why?
|
Health Resources | 1 | 2021 | 911 | 0.130 |
Why?
|
Incidence | 5 | 2020 | 20947 | 0.130 |
Why?
|
Drug Monitoring | 2 | 2018 | 956 | 0.130 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 987 | 0.130 |
Why?
|
Propranolol | 1 | 2016 | 502 | 0.120 |
Why?
|
Algorithms | 1 | 2015 | 13881 | 0.120 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 413 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2017 | 373 | 0.120 |
Why?
|
Factor VIII | 2 | 2013 | 347 | 0.120 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 315 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
von Willebrand Factor | 1 | 2017 | 669 | 0.120 |
Why?
|
Tracheostomy | 1 | 2017 | 401 | 0.120 |
Why?
|
Thoracic Vertebrae | 1 | 2018 | 608 | 0.110 |
Why?
|
Diphosphonates | 1 | 2018 | 623 | 0.110 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 3507 | 0.110 |
Why?
|
Hemangioma | 1 | 2018 | 738 | 0.110 |
Why?
|
Hemoglobinuria | 1 | 2012 | 13 | 0.110 |
Why?
|
Muscle, Skeletal | 3 | 2020 | 4931 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4253 | 0.110 |
Why?
|
Oliguria | 1 | 2012 | 21 | 0.110 |
Why?
|
Interferons | 1 | 2016 | 706 | 0.110 |
Why?
|
Blood Coagulation Tests | 1 | 2013 | 263 | 0.110 |
Why?
|
Lung | 3 | 2022 | 9856 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8642 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12959 | 0.100 |
Why?
|
Spinal Cord | 1 | 2020 | 1809 | 0.100 |
Why?
|
Scoliosis | 1 | 2018 | 725 | 0.100 |
Why?
|
Ventricular Function | 1 | 2013 | 416 | 0.100 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2012 | 111 | 0.100 |
Why?
|
Progesterone Congeners | 1 | 2011 | 42 | 0.100 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 426 | 0.100 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 564 | 0.100 |
Why?
|
Prognosis | 5 | 2019 | 29063 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2016 | 1240 | 0.090 |
Why?
|
Peripheral Vascular Diseases | 1 | 2014 | 550 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 1994 | 839 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2959 | 0.090 |
Why?
|
Metals | 1 | 1994 | 719 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1257 | 0.090 |
Why?
|
Orthopedic Procedures | 1 | 2020 | 1288 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2020 | 63114 | 0.080 |
Why?
|
Recurrence | 2 | 2020 | 8340 | 0.080 |
Why?
|
Alleles | 1 | 2000 | 6933 | 0.080 |
Why?
|
Cell-Derived Microparticles | 1 | 2011 | 168 | 0.080 |
Why?
|
Thromboplastin | 1 | 2011 | 291 | 0.080 |
Why?
|
Adult | 15 | 2021 | 214055 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2265 | 0.080 |
Why?
|
Placenta | 1 | 2018 | 1698 | 0.080 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 1775 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3508 | 0.080 |
Why?
|
Iron-Binding Proteins | 2 | 1998 | 79 | 0.080 |
Why?
|
Catheterization | 1 | 2013 | 1470 | 0.080 |
Why?
|
Mutation | 5 | 2017 | 29786 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2015 | 1416 | 0.070 |
Why?
|
Body Weight | 2 | 2017 | 4669 | 0.070 |
Why?
|
Membrane Proteins | 5 | 2005 | 7880 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.070 |
Why?
|
Awareness | 1 | 2011 | 640 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 1 | 2016 | 2038 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3444 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6489 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 828 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3870 | 0.070 |
Why?
|
Colon | 1 | 2013 | 1772 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3282 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2001 | 1791 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.060 |
Why?
|
Sciatic Nerve | 2 | 1999 | 607 | 0.060 |
Why?
|
Pregnancy | 4 | 2023 | 29144 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4986 | 0.060 |
Why?
|
Cohort Studies | 3 | 2017 | 40561 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15076 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5985 | 0.060 |
Why?
|
Bacteria | 1 | 1994 | 2114 | 0.060 |
Why?
|
Disease Progression | 2 | 2017 | 13284 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14722 | 0.050 |
Why?
|
Anemia | 2 | 2005 | 1506 | 0.050 |
Why?
|
Age Factors | 3 | 2018 | 18370 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2018 | 1462 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 890 | 0.050 |
Why?
|
Brain | 2 | 2020 | 26385 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 1999 | 1116 | 0.050 |
Why?
|
Mononuclear Phagocyte System | 1 | 2001 | 56 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2001 | 5021 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7913 | 0.050 |
Why?
|
Running | 1 | 2006 | 480 | 0.050 |
Why?
|
GTP-Binding Proteins | 1 | 2005 | 970 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39050 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7301 | 0.050 |
Why?
|
Administration, Oral | 2 | 2021 | 3913 | 0.050 |
Why?
|
Glutathione Peroxidase | 2 | 1999 | 255 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4262 | 0.050 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2001 | 326 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2278 | 0.050 |
Why?
|
Hemochromatosis | 1 | 2001 | 184 | 0.040 |
Why?
|
Risk Assessment | 4 | 2018 | 23338 | 0.040 |
Why?
|
Hemoglobins | 1 | 2005 | 1534 | 0.040 |
Why?
|
Vascular Surgical Procedures | 2 | 2018 | 1475 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3528 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12788 | 0.040 |
Why?
|
Iron | 4 | 2005 | 1774 | 0.040 |
Why?
|
United States | 3 | 2018 | 69872 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 35421 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 12804 | 0.040 |
Why?
|
Time Factors | 6 | 2018 | 40075 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 2 | 2017 | 1442 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2001 | 880 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 295 | 0.040 |
Why?
|
Lymphography | 1 | 2018 | 201 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2001 | 2839 | 0.040 |
Why?
|
Pediatrics | 2 | 2018 | 3475 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.040 |
Why?
|
Prospective Studies | 5 | 2023 | 53288 | 0.040 |
Why?
|
Phlebography | 1 | 2018 | 333 | 0.040 |
Why?
|
Protein Kinase C | 2 | 1999 | 1227 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 520 | 0.040 |
Why?
|
Chorioamnionitis | 1 | 2018 | 155 | 0.040 |
Why?
|
Cloning, Molecular | 3 | 2001 | 4320 | 0.040 |
Why?
|
Smoking | 1 | 2013 | 8987 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 458 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 256 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2001 | 2050 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2017 | 195 | 0.030 |
Why?
|
Menkes Kinky Hair Syndrome | 1 | 1994 | 20 | 0.030 |
Why?
|
Glycine | 1 | 1998 | 671 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1723 | 0.030 |
Why?
|
Middle Aged | 7 | 2021 | 213383 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6756 | 0.030 |
Why?
|
Chemoprevention | 1 | 2017 | 319 | 0.030 |
Why?
|
Hepatolenticular Degeneration | 1 | 1994 | 69 | 0.030 |
Why?
|
Arginine | 1 | 1998 | 944 | 0.030 |
Why?
|
Mice, Mutant Strains | 3 | 2005 | 1866 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2014 | 120 | 0.030 |
Why?
|
Plasminogen Inactivators | 1 | 2013 | 38 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 353 | 0.030 |
Why?
|
Diabetic Neuropathies | 1 | 1998 | 400 | 0.030 |
Why?
|
Histidine | 1 | 1994 | 313 | 0.030 |
Why?
|
Platelet Aggregation | 1 | 2017 | 798 | 0.030 |
Why?
|
DNA Probes | 1 | 1994 | 560 | 0.030 |
Why?
|
Protein S | 1 | 2012 | 30 | 0.030 |
Why?
|
beta 2-Glycoprotein I | 1 | 2012 | 28 | 0.030 |
Why?
|
Sodium Tetradecyl Sulfate | 1 | 2012 | 14 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2005 | 18111 | 0.030 |
Why?
|
Spine | 1 | 2020 | 1144 | 0.030 |
Why?
|
Antithrombin III | 1 | 2012 | 128 | 0.030 |
Why?
|
Protein C | 1 | 2012 | 138 | 0.030 |
Why?
|
Sclerosing Solutions | 1 | 2012 | 78 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2012 | 101 | 0.030 |
Why?
|
Animals | 10 | 2011 | 168757 | 0.030 |
Why?
|
Receptors, Transferrin | 2 | 2005 | 296 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2001 | 2564 | 0.030 |
Why?
|
Gene Library | 1 | 1994 | 1074 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2017 | 935 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 355 | 0.020 |
Why?
|
Cell Membrane | 1 | 2001 | 3748 | 0.020 |
Why?
|
Thrombin | 1 | 2013 | 598 | 0.020 |
Why?
|
Cough | 1 | 2014 | 555 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3309 | 0.020 |
Why?
|
Species Specificity | 1 | 1994 | 2478 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 13815 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
Bone and Bones | 1 | 2001 | 2575 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 816 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3479 | 0.020 |
Why?
|
Perioperative Care | 1 | 2017 | 1002 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21746 | 0.020 |
Why?
|
Developing Countries | 1 | 2021 | 2815 | 0.020 |
Why?
|
Arteriovenous Malformations | 1 | 2012 | 396 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2014 | 714 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2018 | 1241 | 0.020 |
Why?
|
Mitochondria | 1 | 2001 | 3520 | 0.020 |
Why?
|
Mice | 8 | 2005 | 81183 | 0.020 |
Why?
|
Naphthalenes | 2 | 1999 | 194 | 0.020 |
Why?
|
Blood Glucose | 2 | 1999 | 6256 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2731 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1616 | 0.020 |
Why?
|
Oxidative Stress | 1 | 1998 | 3086 | 0.020 |
Why?
|
Particle Size | 1 | 2011 | 1642 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1142 | 0.020 |
Why?
|
Ethanol | 1 | 2012 | 1342 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5788 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2634 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2005 | 562 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
Endovascular Procedures | 1 | 2018 | 1979 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3068 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 2005 | 246 | 0.010 |
Why?
|
Base Sequence | 1 | 1994 | 12797 | 0.010 |
Why?
|
Biological Transport | 2 | 1998 | 2118 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 914 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 655 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 520 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5255 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 7023 | 0.010 |
Why?
|
Escherichia coli | 1 | 1994 | 4217 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3279 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2005 | 1526 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9849 | 0.010 |
Why?
|
Physical Chromosome Mapping | 1 | 2001 | 183 | 0.010 |
Why?
|
Lod Score | 1 | 2001 | 614 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4560 | 0.010 |
Why?
|
Codon | 1 | 2001 | 611 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 2005 | 21827 | 0.010 |
Why?
|
Iron Overload | 1 | 2001 | 242 | 0.010 |
Why?
|
Italy | 1 | 2001 | 832 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2001 | 1581 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2001 | 399 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 733 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2001 | 810 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2765 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 1999 | 3798 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 2327 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1997 | 642 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 964 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15540 | 0.010 |
Why?
|
Aged | 2 | 2019 | 163280 | 0.010 |
Why?
|
HLA Antigens | 1 | 2001 | 1381 | 0.010 |
Why?
|
Cytosol | 1 | 1999 | 901 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2437 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1246 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 494 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1997 | 802 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2001 | 1366 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19905 | 0.010 |
Why?
|
Phenotype | 2 | 2001 | 16365 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4644 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5179 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4186 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6386 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.010 |
Why?
|
Haplotypes | 1 | 1997 | 2779 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2804 | 0.010 |
Why?
|
Models, Genetic | 1 | 2001 | 3494 | 0.010 |
Why?
|
Homeostasis | 1 | 2001 | 3340 | 0.010 |
Why?
|
Cell Line | 1 | 2001 | 15997 | 0.000 |
Why?
|
Kidney | 1 | 1998 | 7186 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 19229 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18029 | 0.000 |
Why?
|